SCHEMBL753785

SCHEMBL753785

CC1(C)NC(=O)NC1=O.[Ag]

nearest known ligand 0.44

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ ITGA4 P13612 1/20 0.37
▸ LMNA P02545 2/20 0.36
▸ MMP2 P08253 2/20 0.34
▸ MMP9 P14780 2/20 0.34
▸ CACNA1F O60840 1/20 0.34
▸ ALDH1A1 P00352 1/20 0.34
▸ MAPT P10636 1/20 0.34
▸ CYP2C9 P11712 1/20 0.34
▸ HTR2A P28223 1/20 0.34
▸ HRH1 P35367 1/20 0.34
▸ SCN1A P35498 1/20 0.34
▸ SCN4A P35499 1/20 0.34
▸ BLM P54132 1/20 0.34
▸ PMP22 Q01453 1/20 0.34
▸ CACNA1D Q01668 1/20 0.34
▸ KCNH2 Q12809 1/20 0.34
▸ CACNA1S Q13698 1/20 0.34
▸ CACNA1C Q13936 1/20 0.34
▸ SCN5A Q14524 1/20 0.34
▸ SCN2A Q99250 1/20 0.34

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL22069 0.97 — —
SCHEMBL4558728 0.97 LMNA (0.38) ITGA4LMNAMMP2MMP9CACNA1F
SCHEMBL21196916 0.94 — —
SCHEMBL6162987 0.94 LMNA (0.36) ITGA4LMNAMMP2MMP9CACNA1F
Formaldehyde SCHEMBL1396256 0.92 LMNA (0.35) ITGA4LMNAMMP2MMP9CACNA1F
Methyl Alcohol SCHEMBL7188450 0.92 MMP2 (0.35) ITGA4LMNAMMP2MMP9CACNA1F
Ethylene Glycol SCHEMBL6848838 0.85 LMNA (0.36) LMNAMMP2MMP9POLBSMN1; SMN2
Butadiene SCHEMBL1304779 0.85 GAA (0.32) LMNAMMP2MMP9CACNA1FALDH1A1
SCHEMBL3176115 0.83 ADAMTS5 (0.32) LMNAMMP2POLBAKR1B1
SCHEMBL10527679 0.83 AKR1B1 (0.31) LMNAAKR1B1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 32 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20250354268-A1 COMPOSITION, METHOD FOR PRODUCING COMPOSITION, AND METHOD FOR PRODUCING SILVER FILM ADEKA CORPORATION (JP) 2025-11-20 — — US claimed
CN-115216812-A Electrochemical preparation method of three-dimensional silver-based microstructure with high depth-to-width ratio 上海交通大学 2022-10-21 — — CN claimed
WO-2010065090-A2 ANTIMICROBIALS KING TECHNOLOGY, INC. (US) 2010-06-10 — — WO claimed
US-20100143430-A1 Antimicrobial agents KING JOSEPH A 2010-06-10 — — US claimed
US-20250354268-A1 COMPOSITION, METHOD FOR PRODUCING COMPOSITION, AND METHOD FOR PRODUCING SILVER FILM ADEKA CORPORATION (JP) 2025-11-20 — — US disclosed
WO-2023243394-A1 COMPOSITION, METHOD FOR PRODUCING COMPOSITION, AND METHOD FOR PRODUCING SILVER FILM 株式会社ADEKA 2023-12-21 — — WO disclosed
CN-115216812-A Electrochemical preparation method of three-dimensional silver-based microstructure with high depth-to-width ratio 上海交通大学 2022-10-21 — — CN disclosed
EP-2634293-B1 COMPOSITES OF CARBON BLACK AND METAL ROHM & HAAS ELECT MAT (US) 2018-07-18 — — EP disclosed
EP-2431502-B1 CYANIDE-FREE SILVER ELECTROPLATING SOLUTIONS ROHM & HAAS ELECT MAT (US) 2017-05-24 — — EP disclosed
US-20160096752-A1 WASTEWATER TREATMENT KING JOSEPH A (US) 2016-04-07 — — US disclosed
US-9228268-B2 Method of electroplating silver strike over nickel ROHM AND HAAS ELECTRONIC MATERIALS LLC 2016-01-05 — — US disclosed
US-9187351-B2 Water treatment KING TECHNOLOGY INC. (US) 2015-11-17 — — US disclosed
WO-2011056203-A2 WATER TREATMENT KING TECHNOLOGY, INC. (US) 2011-05-12 — — WO disclosed
US-20110094972-A1 Water treatment KING TECHNOLOGY, INC. 2011-04-28 — — US disclosed
US-20100140185-A1 Wastewater treatment HILL JOHN 2010-06-10 — — US disclosed
CN-1753702-A An assembly for the preparation of a medical device having a coating comprising hydrogen peroxide COLOPLAST AS (DK) 2006-03-29 — — CN disclosed
EP-1062383-A4 ELECTROLYTE AND TIN-SILVER ELECTROPLATING PROCESS LEARONAL INC (US) 2002-08-14 — — EP disclosed
US-6210556-B1 FOR DEPOSITING TIN-RICH TIN-SILVER ALLOYS UPON A SUBSTRATE LEARONAL, INC. 2001-04-03 — — US disclosed
EP-1062383-A1 ELECTROLYTE AND TIN-SILVER ELECTROPLATING PROCESS LeaRonal, Inc. (US) 2000-12-27 — — EP disclosed
WO-1999041433-A1 ELECTROLYTE AND TIN-SILVER ELECTROPLATING PROCESS LEARONAL, INC. (US) 1999-08-19 — — WO disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20110094972-A1 Water treatment HNMT, NAAA, MPO ITGA4 4615/4885LMNA 4253/4885MMP2 178/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.

Send feedback